Inventiva draws down the second tranche of €25 million under existing Finance Contract with the European Investment Bank

Inventiva intends to use the proceeds to fund part of its ongoing pivotal NATiV3 Phase III clinical trial evaluating lanifibranor in patients with...

Related Keywords

United States ,New York ,Daix ,Bourgogne ,France ,Ukraine ,Israel ,Russia ,French ,Pascaline Clerc ,Jean Volatier ,Aude Lepreux ,Exchange Commission On ,European Investment Bank ,Patricial Bank ,Company Nati ,Nasdaq ,Brunswick Group ,Corporate Affairs ,Long Island City ,Euronext Paris ,Finance Contract ,Deputy Chief Executive Officer ,Chief Financial Officer ,French Commercial Code ,Nasdaq Global Market ,Roquet Montegon ,Private Securities Litigation Reform Act ,New Drug Application ,Universal Registration Document ,Des March ,Annual Report ,Exchange Commission ,Half Year Report ,